This study aims to assess a meta-analysis of the association of X-ray repair cross-complementing group 1 (XRCC1) polymorphisms with the risk of various non-carcinogenic diseases in different population. MATERIALS AND METHODS: This meta-analysis was performed by critically reviewing reveals 38 studies involving 10043 cases and 11037 controls. Among all the eligible studies, 14 focused on Arg194Trp polymorphism, 33 described the Arg399Gln and three articles investigated on Arg280His. Populations were divided into three different ethnic subgroups include Caucasians, Asians and other (Turkish and Iranian). RESULTS: Pooled results showed no correlation between Arg194Trp and non-carcinogenic disease. There was only weak relation in the recessive (odds ratio [OR] =1.11, 95% confidence interval [CI]: 0.86-1.44) model in Asian population and dominant (OR = 1.04, 95% CI: 0.66-1.63) model of other populations. In Arg399Gln polymorphism, there was no relation with diseases of interest generally. In the pooled analysis, there were weak relation in the dominant (OR = 1.08, 95% CI: 0.86-1.35) model of Asian population and quite well-correlation with recessive (OR = 1.49, 95% CI: 1.19-1.88), dominant (OR = 1.23, 95% CI: 0.94-1.62), and additive (OR = 1.23, 95% CI: 0.94-1.62) models of other subgroup. For Arg280His, there was a weak relation only in the dominant model (OR = 1.06, 95% CI: 0.74-1.51). CONCLUSION: The present meta-analysis correspondingly shows that Arg399Gln variant to be associated with increased non-carcinogenic diseases risk through dominant and recessive modes among Iranian and Turkish population. It also suggests a trend of dominant and recessive effect of Arg280His variant in all population and its possible protective effect on non-carcinogenic diseases.
Introduction
There is increasing evidence suggests that damage to human deoxyribonucleic acid (DNA) might initiate the cancer, which caused by external agents such as chemical agents, ionizing radiation and ultraviolet (UV). [1] [2] [3] The X-ray repair cross-complementing group 1 (XRCC1) is a DNA repair gene and a number of its single nucleotide polymorphisms (SNPs) have been considered as a modifying risk factor for a variety of cancer types.
Three different polymorphisms in XRCC1 gene have been identified at codon 399 (Arg to Gln), 194 (Arg to Trp) and 280 (Arg to His) until now, [4] which were predicted to be possibly damaging the XRCC1 function. [5] The interactions of XRCC1 and its substrate result in assembly of the repair complex at the site of damage and regulate the activity of several repair enzymes. [6] The polymorphism Arg399Gln changes XRCC1's structure and maybe disrupt the combination of several repair enzymes, particularly poly (ADP-ribose) polymerase 1 (PARP1).
Arg194Trp and Arg280His also change XRCC1's structure, but maybe not influence the function of XRCC1.
Previous analysis of case-control reports is the most predominant method of exploring the association between a specific gene and a disease. However, studies on XRCC1 polymorphisms in cancer have provided challenging and controversial results so far. Although other studies have found that the XRCC1 increase in breast cancer risk, [7, 8] and reports showed a possible protective effect, [9] while many studies observed no significant association between these polymorphisms and the disease. [10] Besides it was reported thatXRCC1 gene polymorphism is associated with several cancers including lung, esophageal, and prostate cancers, among different population. [11] [12] [13] [14] [15] [16] Moreover, no evidence of any associations between Arg399Gln polymorphism and bladder cancer susceptibility has not shown, [17] hence other researchers reported that 399 Gln/Gln genotype is associated with a risk of lung cancer among Asians ethnicity, [18] and breast cancer in African Americans. [19] There are fairly few studies lead to observe the relationship between cancer risk and Arg280His variant up to the present time, only a single study revealed this association. [20, 21] Although, large numbers of epidemiologic studies have been evaluated the role of XRCC1 polymorphisms on various non-carcinogenic diseases, such as liver cirrhosis, Alzheimer, glaucoma, cataract, human immunodeficiency virus-1/acquired immunodeficiency syndrome, schizophrenia, type 2 diabetes and cancers, but no such comprehensive analysis in the field of non-carcinogenic disease, is reported so far.
Nevertheless, a meta-analysis of all existing reports will help to create a more convincing result, because some of these studies were based on a small sample size, thus, subgroup analysis based on ethnic and other factors may also yield more meaningful results. It is important to perform a quantitative synthesis of the available evidence using more rigorous methods on the amounts of evidence have been accumulated so far. Therefore, we performed a meta-analysis of all eligible case-control studies published to date, to assess the association of XRCC1 polymorphisms with the risk of various non-carcinogenic diseases in different population.
Materials and Methods

Study selection
Relevant studies were identified in the PubMed, ISI web of science and Scopus using combinations of the search phrases "X-ray cross-complementing group 1," "polymorphism,'' "DNA repair gene" and all possible combination (the last search update on October 12, 2012 ). In addition, all publications in other databases such as IranMedex, scientific information database were searched. In a total of 383 retrieved relevant references, 38 publications were identified to be eligible for inclusion in the meta-analysis. These studies had a case-control study design that assessed the association between the XRCC1 Arg194Trp, the Arg399Gln and Arg280His polymorphisms and risk of non-carcinogenic diseases using human genomic DNA samples.
Inclusion criteria Study design
Case-control studies were included in the evaluation, since this study design allows a comparison to be made between the affected individuals and healthy or disease-free ones, which is essential for the meta-analysis model.
Participants
Studies that included patients with any non-tumorigenic or non-carcinogenic condition were included in the evaluation.
Exclusion criteria
Studies that were not representative or not case-control were excluded. The studies that showed not enough data for analysis were excluded after contacting corresponding author twice.
Data extraction
Two reviewers independently screened all titles and abstracts. Full paper manuscripts of any titles/abstracts that appeared to be relevant were obtained where possible and the relevance of each study independently assessed by two reviewers according to the inclusion and exclusion criteria. Two authors (FR and NS) mined data and reached an agreement on all of the eligibility items, including author, journal and year of publication, location of study, selection and characteristics of cases and controls, control source, demographics, ethnicity and genotyping information.
Meta-analysis
The odds ratios (OR) of selected non-carcinogenic diseases associated with the XRCC1 Arg194Trp, the Arg399Gln and Arg280His polymorphisms were estimated for each study independently. We estimated the risk first for the variant homozygous genotypes, compared with the wild-type homozygous genotypes, assuming recessive and dominant effect models, respectively.
Statistical analysis
We calculated OR and 95% of confidence intervals (CI) to estimate non-carcinogenic risk associated with the XRCC1 polymorphism for each study. Inevitably, studies included in the meta-analysis differed in the variables of interest and thus, any kind of variability among studies may be termed heterogeneity. In meta-analysis, we examined the association between In the present study, both Der Simonian and Laird's random-effects method and Mantel-Haenszel's fixed-effects (FEs) method were used. In the meta-analysis, to evaluate the between-study heterogeneity both Chi-square-based Q-statistic and I-squared (I 2 ) tests were performed. Furthermore, according to Venice criteria, for the I 2 test included: <25% represents no heterogeneity, =25-50% represents moderate heterogeneity, =50-75% represents large heterogeneity and > 75% represents extreme heterogeneity. [57] So the heterogeneity was considered significant, if the P < 0.10 and I 2 > 25, a random-effect model was suitable, otherwise if the P ≥ 0.10and I 2 ≤ 25, a FE model was then used to estimate summary ORs and 95% CIs. Publication bias was assessed by a funnel plot based on the Egger's regression test and a t-test was implemented to determine the significance of the asymmetry. An asymmetric plot suggested possible publication bias (P ≥ 0.05 suggests no bias). All analyses were performed using STATA 11.0 (StataCorp LP, Lakeway Drive, College Station, Texas, USA). All the P values were two-sided.
Results
Eligible studies
Thirty-nine reports focused on the role of any polymorphism of the XRCC1 gene in the non-carcinogenic risk were reviewed [ Figure 1 ]. Four combined analysis include 3 individual case-control studies, two of which were also reported by Yousaf et al., [26] Ferguson et al., [45] and Olshan et al., [49] Trp/Trp  Caucasian  Rossit, 2002  97  82  14  1  92  96  79  17  0  91  Age, sex and ethnicity  Bazo, 2009  117  40  6  0  93  52  28  10  1  85  Age and sex  Frank, 2011  533  106  246  171  96  1054  192  506  342  99  Subtotal  650  228  266  172  -1202  299  533  343  -Asian  Koyama, 2006  40  5  13  21  63  102  16  44  42  71  Age and ethnicity  Gu, 2007  176  77  74  20  67  248  101  119  27  65  Age and sex  XIE, 2009  201  112  72  17  74  309  143  130  36  68  Age and , 2002  97  37  48  12  63  96  49  34  13  69  Age, sex and ethnicity  Olshan, 2005  125  58  50  15  68  350  135  155  35  66  -Olshan, 2005  125  53  54  11  68  350  135  155  35  66  -Ferguson, 2008  230  99  104  27  62  248  100  115  33  63  Age, sex and ethnicity  Ferguson, 2008  212  73  113  26  62  248  100  115  33  63  Age, sex and ethnicity  Bazo, 2009  117  25  0  0  54  52  20  0  0  85  Age and sex  Sterpone, 2009  93  36  39  18  60  63  27  25  11  63  Age and sex  Kasznicki, 2009  94  35  40  19  59  101  29  49  23  53  Subtotal  1093  416  448  128  -1508  595  648  183  -Asian  Koyama, 2006  40  5  13  22  74  102  9  34  59  71  Age and ethnicity  Zhao, 2006  104  16  12  23  43  101  19  22  12  57  Gu, 2007  176  102  64  5  88  248  101  119  27  83  Age and sex  XIE, 2009  201  112  72  17  74  309  143  130  36  68  Age and sex  Yang, 2009  201  95  91  15  70  309  175  111  23  75  Age, sex and ethnicity  Sobti, 2009  300  111  126  63  58  300  133  125  42  65  Age and sex  Lin, 2009  172  10  83  71  69  160  21  78  120  73  -Ji, 2010  984  327  239  54  72  620  153  97  23  74  Age and sex  Chiang, 2010  127  9  70  48  65  103  5  31  67  80  Age  Chen, 2010  83  31  35  17  68  206  104  80  22  69  Padma, 2011  208  90  82  36  63  151  75  56  20  68  Age and sex  Yousaf, 2011  160  17  73  70  67  193  30  65  98  68  Age and sex  Yousaf, 2011  163  28  56  79  66  193  30  65  98  68  Age and sex  Luo, 2011  180  13  71  96  73  174  14  45  115  79  Age and sex  Subtotal  3099  966  1087  616  -3169 1012  1058  762  -Other population  Ünal, 2007  195  65  100  30  59  194  58  115  21  60  Age, sex and ethnicity  Gϋven, 2007  147  50  76  21  60  48  12  33  3  59  Age and sex  Gϋven, 2007  144  56  78  10  65  121  34  76  11  60  Age and sex  Bau, 2007  141  7  75  59  68  100  15  55  30  58  Age, sex and BMI  Saadat, 2008  303  100  159  44  60  303  132  142  29  67  Age and sex  Parildar-Karpuzoğlu,  2008   91  35  49  7  67  93  49  46  8  66  Age and sex   Vural, 2009  101  39  48  14  63  107  44  53  10  66  Age and sex  Attar, 2010  153  40  12  0  65  101  86  15  0  68  sex  Görgϋn, 2010  120  60  46  14  69  205  99  85  21  69  Age, sex and ethnicity  Batar, 2010  116  39  57  20  58  309  91  71  18  70  Age and ethnicity  Attar, 2010  52  40  12  0  101  86  15  0  Subtotal  1563  531  712  219  -1682  706  706  151  -Total  5755 1913  2247  963  -6359 2313  2412 
Arg280His
There were only three studies (1115 cases and 815 controls) involving one Caucasian and 2 Asian reports, that investigating the relation of XRCC1 Arg280His polymorphism and the risk of non-carcinogenic disease.
We examined the relationship between Arg280His XRCC1 polymorphism and non-carcinogenic diseases risk, assuming various inheritance models of the 280His allele for each individual study [ Table 4 ].
There was no between-study heterogeneity in 
Sensitivity analysis
W e i m p l e m e n t e d s e n s i t i v i t y a n a l y s e s t o assess the effect of those studies that are not in Horner-Wadsworth-Emmons. [28, 36, 38, 44] The results The present analyses of hospital based and population-based studies individually also did not lead to a different conclusion. In addition, meta-regression did not find a significant difference between various study designs.
Publication bias
Funnel plots and Egger's test were performed to assess publication bias, which suggested that there were no publication bias for the comparison of Arg399Gln polymorphism, in term of recessive (t = 1.07, P = 0.294), dominant (t = 0.39, P = 0.701) and additive (t = −0.57, Figure 7 and Table 5 ]. Furthermore, there were no publication bias for the comparison of Arg194Trp polymorphism, in term of recessive (t = −0.01, P = 0.995), dominant (t = −0.19, P = 0.854) and additive (t = −0.12, P = 0.910) models [ Figure 9 and Table 5 ]. Besides, there were no publication bias for the comparison of Arg280His polymorphism, in term of recessive (t = 3.13, P = 0.197), dominant (t = −1.08, P = 0.475) and additive (t = −0.00, P = 0.997) models [ Figure 11 and Table 5 ].
However, when we stratified Arg399Gln, Arg194Trp and Arg280His polymorphisms, according to different ethnic subgroups include Caucasian, Asian and other; there was no public bias in each subgroup [Figures 8, 10, 12 and Table 5 and 6]. 
Discussion
Large and unbiased molecular and genetic epidemiologic studies of SNPs such as DNA repair Many of the studies indicated the association between the oxidative or UV light DNA damage and cataract development, [58] [59] [60] [61] [62] that the contribution of DNA damage in cataract pathogenesis indicate the role of DNA repair enzymes such as XRCC1. An epidemiologic study that reviewed twenty-two researches revealed a well-documented risk for cataract and DNA damage due to UV exposure. [63] Previous studies showed no association between Arg194Trp polymorphism and indicators of DNA repair capacity, such as, sensitivity to ionizing radiation or DNA-adduct levels. [64] Hence, our meta-analysis found evidence that 194Trp variant altered non-carcinogenic disease risk among Asian populations. However, other studies showed that this polymorphism exhibited significantly lower values of chromosomal breaks per cell and the protective effect of 194Trp. [65, 66] Studies suggest that Arg194Trp polymorphism does not modify the risk for non-carcinogenic disease including alcoholic cirrhosis, pre-eclampsia (PE) and idiopathic azoospermia in Asian, Caucasian and other population, [24, 32, 42] while some studies showed a protective effect against other disease such as chronic obstructive pulmonary disease (COPD) and Pterygiumin Asian population. [43, 53] In some meta-analysis about the association between Arg194Trp and risk of cancer considering different genetic models, no evidence of the protective effect against the bladder and breast cancer has been found in Asian and Caucasian. [17, [67] [68] [69] However, others showed Arg280His genotype increased risk for differentiated thyroid carcinoma and gastric cardiac adenocarcinoma in the dominant model, while mildly reduced the risk for this cancer in Asian and Other (Iranian) population. [70, 71] Our meta-analysis also recommends a tendency towards recessive mode of risky effect of 194Trp, which suggest that further studies should be performed to evaluate the effect of this polymorphism.
Moreover, for XRCC1-Arg399Gln polymorphism studies showed that this polymorphism may modify the risk for the non-carcinogenic disease including alcoholic cirrhosis, PE, Alzheimer's disease (AD), ocular diseases include primary open angle glaucoma, cataract, Pterygium, severe chronic atrophic gastritis and idiopathic azoospermia in Asian, Caucasian and other population, [23, 24, 27, 29, 30, 32, 42, 43, 68] while some studies showed no association with other disease such as COPD and endometriosis in Asian and other population. [31, 53] Several well-known atherosclerotic risk factors, such as dyslipidemia and diabetes mellitus, lead to DNA damage, [69] thus the effects of this risk factors on DNA damage in coronary artery disease (CAD) have been demonstrated formerly [70, 71] and found no associations between CAD and Arg399Gln polymorphism in other (Turkey) population [34] whereas, other study showed a relationship between CAD and Arg399Gln, polymorphisms in Caucasian. [35] In cystic fibrosis, there was slight correlation between Arg399Gln polymorphism with liver status and pancreatic insufficiency in Caucasian, but this correlation was not significant. [36] In a meta-analysis of Asian (Taiwanese Han Chinese) and
Caucasian (Brazilian, and Polish) populations showed that the XRCC1 (Arg399Gln polymorphism) was associated with systemic lupus erythematous incidence. [40] Furthermore, the XRCC1 (Arg399Gln polymorphism) may affect risk of two major birth defects including spina bifida and oral clefts in Caucasian (USA) population. [49] The majority of studies have reported that there was no association between the XRCC1 (codon 399) polymorphism and cancer. [72] [73] [74] [75] [76] [77] [78] [79] In the minority of researches, a weak but statistically significant association has been found in Asian countries, entirely. [18, [72] [73] [74] Our meta-analysis suggests that 399Gln increases non-carcinogenic disease risk by 50%, 25% and 60% with recessive, dominant and additive models in other population only, respectively, which indicated that the genotype distributions of Arg399Gln varied with ethnicity.
There may be two explanations concerning the difference in results. Genetic, environmental, and ethnic differences in allele frequency for the investigated polymorphisms can affect results in studies. One possible explanation could be differences in ethnicity in term of dietary habits and drinking, health-care access and socioeconomic factors. Another more reasonable clarification may be linked to diversity in linkage or genetic associations between alleles in different populations, which formerly were reported in cancer. [80] From the Biological point of view, 280His codon is placed in the proliferating cell nuclear antigen-binding region. Previously, it was suggested 280His codon to be associated with higher bleomycin sensitivity, which resulted in a reduced DNA repair capacity produced by bleomycin. [71] Studies showed that XRCC1-Arg280His polymorphism had a protective effect on non-carcinogenic disease such as AD, rheumatoid arthritis in other (Turkish) and
Asian (Taiwanese and Japanese) population, [23, 46, 61] while does not meet the frequency criteria for being considered an important SNP in some non-carcinogenic disease like ocular disease (Pterygium), severe chronic atrophic gastritis, spina bifida and oral clefts among Asian (Chinese) and Caucasian (Irish and American) population. [38, 44, 45, 49] Our meta-analysis suggests a tendency for Asian and Caucasian populations harboring Arg280His to have a protective effect against non-carcinogenic disease through both recessive and dominant effect [ Table 5 ]. These varying effects in Asian and Caucasian populations may be due to the difference in distributions of this SNP, with a lower frequency in Caucasian population (4-6%) when compared with Asian population [ Table 4 ]. As studies of 
Conclusion
The present meta-analysis correspondingly shows that comprising diverse population is very important since susceptibility loci might vary indifferent ethnic groups.
To ratify our findings, widespread studies with enlarged sample size and various populations are essential to explain the role of all polymorphism ofXRCC1 genes in the pathogenesis of non-carcinogenic diseases. Finally, our meta-analysis showed Arg399Gln variant to be associated with increased non-carcinogenic diseases risk through dominant and recessive modes among Iranian and Turkish population. It also suggests a trend of dominant and recessive effect of Arg280His variant in all population and its possible protective effect on non-carcinogenic diseases as well.
